Two years ago, one of Elaine Riddell’s consulting clients approached her with a simple question: what U.S. firms with over $20 million in revenue could they pursue from an M&A perspective that were in ...
The European market for orphan drugs presents many opportunities and challenges for pharma companies. With over 30 million people in the EU living with rare diseases, the demand for innovative ...
insights from industryDonovan QuillExecutive Vice President of Growth and StrategyAscellaHealth In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth and Strategy ...
Fingerpaint Group has secured yet another acquisition to boost its portfolio, this time expanding its market access capabilities. On Wednesday, the MM+M 2024 Agency 100 honoree announced that it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback